Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xtant Medical

0.6777
-0.0174-2.50%
Volume:20.39K
Turnover:14.10K
Market Cap:94.42M
PE:-7.63
High:0.7149
Open:0.7000
Low:0.6760
Close:0.6951
Loading ...

Retrieve Medical Holdings and MyID Announce Joint Venture to Launch First Wearable Electronic Health Record

Reuters
·
28 May

Xtant Medical Unveils OsteoFactor Pro™, Revolutionizing Bone Healing with Innovative Growth Factor Solution

Reuters
·
28 May

Xtant Medical Reports Strong Q1 2025 Results

TIPRANKS
·
13 May

Xtant Medical files to sell 73.11M shares of common stock for holders

TIPRANKS
·
13 May

BRIEF-Xtant Medical Reports First Quarter 2025 Financial Results

Reuters
·
13 May

Xtant Medical Hldgs Q1 Sales $32.90M Beat $31.20M Estimate

Benzinga
·
13 May

Xtant Medical Q1 Revenue USD 32.9 Million

THOMSON REUTERS
·
13 May

Xtant Medical Holdings Inc. Reports 18% Revenue Increase and Achieves Positive Net Income for Q1 2025

Reuters
·
13 May

Adagio Medical Holdings Inc. Files Initial Beneficial Ownership Statement for Interim CFO George Dan

Reuters
·
29 Apr

Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance

PR Newswire
·
23 Apr

BRIEF-Xtant Medical Announces Secondary Private Sale Of Existing Shares By Orbimed

Reuters
·
16 Apr

Xtant Medical Holdings Inc Outlook Q1 Revenue $32.8 Mln and $33.1 Mln

THOMSON REUTERS
·
16 Apr

Xtant Medical Announces Secondary Private Sale of Existing Shares by Orbimed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

THOMSON REUTERS
·
16 Apr

Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

PR Newswire
·
16 Apr

Xtant Medical Faces Risk of Share Distribution by Major Stakeholder, Threatening Stock Stability

TIPRANKS
·
08 Mar

Xtant Medical’s Earnings Call: Mixed Outlook with Growth Plans

TIPRANKS
·
08 Mar

Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE), Lexicon Pharmaceuticals (LXRX) and Xtant Medical Holdings (XTNT)

TIPRANKS
·
07 Mar

Xtant Medical Reports Strong 2024 Revenue Growth

TIPRANKS
·
07 Mar

Xtant Medical Hldgs Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $31.51M Miss $31.80M Estimate

Benzinga
·
07 Mar

Xtant Medical Q4 Gross Margin 50.8%

THOMSON REUTERS
·
07 Mar